Respiratory Syncytial Virus and Human Metapneumovirus Respiratory Hospitalizations and Outcomes in Colorado Adults ≥50 Years of Age: 2016–2023 - Takeaways - MDSpire

Respiratory Syncytial Virus and Human Metapneumovirus Respiratory Hospitalizations and Outcomes in Colorado Adults ≥50 Years of Age: 2016–2023

  • By

  • Eric A F Simões

  • Robert J Suss

  • Dhananjay Raje

  • July 16, 2025

  • 0 min

Share

  • 1

    RSV is a significant cause of hospitalization and mortality in adults aged 50 and older, while HMPV's impact is less recognized.

  • 2

    COPD is a major risk factor for ICU admission in both RSV and HMPV infections among older adults.

  • 3

    Neurological disorders with dementia significantly increase mortality risk in RSV-infected patients, unlike HMPV.

  • 4

    HMPV infection shows a distinct disease burden with specific high-risk comorbidities compared to RSV.

  • 5

    This study utilized a comprehensive database from 93 Colorado hospitals to analyze hospitalization outcomes for RSV and HMPV.

Original Source(s)

Respiratory Syncytial Virus and Human Metapneumovirus Respiratory Hospitalizations and Outcomes in Colorado Adults ≥50 Years of Age: 2016–2023

  • by Eric A F Simões, Robert J Suss, Dhananjay Raje

  • July 16, 2025

Related Content

Prevalence of Aspergillus spp. in Patients Exhibiting Tuberculosis-like Symptoms in Yaoundé, Cameroon, and Analysis of Antifungal Resistance Patterns

N-acetylcysteine: evidence based consensus document on the therapeutic advantages in respiratory diseases (NECTAR)

Post-pandemic resurgence of Mycoplasma pneumoniae and its emerging link with Rhinovirus in children